Breaking it down: a systematic review unravelling the impact of attention deficit hyperactivity disorder and methylphenidate on childhood fractures - Garg G, Umeano L, Iftikhar S, Alhaddad SF, Paulsingh CN, Riaz MF, Khan S.
Limb fractures are a common cause of pediatric hospital admissions and surgeries, with a significant prevalence in the United Kingdom across all injury categories. Among psychiatric conditions in children, attention deficit hyperactivity disorder (ADHD) st... (Source: SafetyLit)
Source: SafetyLit - April 26, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Logistic regression analysis of risk factors for pediatric burns: a case-control study in underdeveloped minority areas in China - Lin Z, Iyappan P, Huang Z, Sooranna SR, Wu Y, Lan L, Huang C, Liang F, Zhao D, Huang D.
BACKGROUND: Pediatric burns are common, especially in underdeveloped countries, and these can physically affect the children involved and have an impact on their mental health. The aim of the present study was to assess the effect of pediatric burns in und... (Source: SafetyLit)
Source: SafetyLit - April 26, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
10 years after Flint, the fight to replace lead pipes across the U.S. continues
Ten years ago, Flint, Mich. switched water sources to the Flint River. The lack of corrosion control in the pipes caused lead to leach into the water supply of tens of thousands of residents. Pediatrician Mona Hanna-Attisha recognized a public health crisis in the making and gathered data proving the negative health impact on Flint's young children. In doing so, she and community organizers in Flint sparked a national conversation about lead in the U.S. water system that persists today. Today on the show, host Emily Kwong and science correspondent Pien Huang talk about the state of Flint and other cities with lead pipes. E...
Source: NPR Health and Science - April 26, 2024 Category: Consumer Health News Authors: Emily Kwong Source Type: news
Europe and the Puberty Blocker Debate Europe and the Puberty Blocker Debate
England is undergoing a seismic shift in its approach to managing gender dysphoria in children. The move is part of a wider reconsideration of the evidence.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - April 25, 2024 Category: Psychiatry Tags: Pediatrics News Source Type: news
Pediatric and young adult trauma recidivism - Lehane A, Wood E, Pranikoff S, Avery M, Pranikoff T.
INTRODUCTION: Unintentional injury is the leading cause of death among children. Much can be gleaned from the adult literature in understanding the characteristics that lead to recidivism in efforts to establish interventions for prevention. Our study aims... (Source: SafetyLit)
Source: SafetyLit - April 25, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
A Test Told Me I ’m Basically Made of Plastic. You Probably Are Too
I might like to think of my body as a thing of bone and blood and tissue and water, but as I recently learned, it’s also a thing of plastic—home to an alarming amount of plastic toxins known as bisphenols. Used to manufacture mostly hard, durable plastics—such as water bottles and takeout containers—bisphenols are often found in the company of phthalates, which are used to make more flexible plastics such as raincoat linings, vinyl boots, and packing tape. Both types of chemicals are known to be hormone disruptors, leading to numerous health problems, including early puberty, obesity, heart disease,...
Source: TIME: Health - April 25, 2024 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Environment Source Type: news
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric …
XOMA is entitled to a mid-single digit royalty on global OJEMDA™ sales First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation EMERYVILLE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- XOMA…#ojemda #fda #raf #v600 #emeryville #xomacorporationxoma #nda #braf #owenhughes #xoma (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2024 Category: Consumer Health News Source Type: news
Most Expectant Moms Say They're Likely to Get Maternal RSV Vaccine
(MedPage Today) -- A majority of pregnant individuals or those trying to become pregnant were interested in getting a maternal respiratory syncytial virus (RSV) vaccine once it became available, a nationwide survey found.
Of 1,528 respondents... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 25, 2024 Category: Pediatrics Source Type: news
USDA Updates Rules for School Meals That Limit Added Sugars for the First Time
(MedPage Today) -- The nation's school meals will get a makeover under new nutrition standards that limit added sugars for the first time, the U.S. Department of Agriculture announced Wednesday.
The final rule also trims sodium in kids' meals... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 24, 2024 Category: Pediatrics Source Type: news
GenAI company Alaffia Health raises $10M and more digital health fundings
Pediatric chronic care company Clarity Pediatrics also secured $10 million in seed funding and Los Angeles-based Handl Health brought in $2.5M. (Source: mobihealthnews)
Source: mobihealthnews - April 24, 2024 Category: Information Technology Source Type: news
Pediatric Cancer Patients Declare "No Cape" the Winner in New Superhero Survey
Pediatric cancer patients, survivors, and their siblings have declared, "No Cape" reigns supreme. NEW YORK, April 24, 2024 /PRNewswire-PRWeb/ -- The Tom Coughlin Jay Fund Foundation, Tyler Robinson Foundation (TRF), and the V Foundation for Cancer Research have formed a league of their... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 24, 2024 Category: Pharmaceuticals Tags: NPT CHI SVY Source Type: news
Behavior problems 7 years after severe childhood traumatic brain injury: results of the Traumatisme Grave de L'Enfant study - C âmara-Costa H, Tokpo L, Francillette L, Toure H, Brugel D, Laurent-Vannier A, Meyer P, Dellatolas G, Chevignard M.
PURPOSE/OBJECTIVE: To investigate the occurrence of behavioral problems 7 years after severe pediatric traumatic brain injury (TBI), and their evolution from 3 months to 7 years postinjury. METHOD/DESIGN: Thirty-four participants, 38% girls, M (SD)... (Source: SafetyLit)
Source: SafetyLit - April 24, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Variables Associated with days of school missed following concussion: results from the Sport Concussion Outcomes in PEdiatrics (SCOPE) study - Roberts J, Wilson JC, Halstead ME, Miller SM, Santana JA, Valovich McLeod TC, Zaslow TL, Master CL, Grady MF, Snedden TR, Fazekas ML, Coel RA, Howell DR.
OBJECTIVE: To understand factors associated with missed academic time after concussion to improve support for patients. Our goal was to assess patient-specific predictors of total school time lost after pediatric/adolescent concussion. STUDY DESIGN: We per... (Source: SafetyLit)
Source: SafetyLit - April 24, 2024 Category: International Medicine & Public Health Tags: Recreational and Sports Issues Source Type: news
Trends in pediatric emergency department transfers from Indian Health Service and tribal health systems - Pirrocco FA, Temkit H, Mechem C, Yeager K.
OBJECTIVE: To describe the frequency and observed trends for all Indian Health Service (IHS) and tribal emergency department (ED) transfers to a pediatric referral center from January 1, 2017, to December 31, 2020, with a secondary analysis to describe tre... (Source: SafetyLit)
Source: SafetyLit - April 24, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Novartis Radioligand Therapy Lutathera FDA Approved as First Medicine Specifically for Pediatric Patients with Gastroenteropancreatic Neuroendocrine Tumors
Basel, April 23, 2024 -- Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 23, 2024 Category: Drugs & Pharmacology Source Type: news
